WEST PHARMACEUTICAL SERVICES (1WST.MI) Stock Price & Overview

BIT:1WST • US9553061055

Current stock price

214 EUR
+214 (+Infinity%)
Last:

The current stock price of 1WST.MI is 214 EUR.

1WST.MI Key Statistics

Market Cap
15.412B
P/E
33.91
Fwd P/E
30.50
EPS (TTM)
6.31
Dividend Yield
0.32%

1WST.MI Stock Performance

Today
undefined%
1 Week
N/A
1 Month
N/A
3 Months
N/A
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

1WST.MI Stock Chart

WEST PHARMACEUTICAL SERVICES / 1WST Daily stock chart

1WST.MI Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to 1WST.MI.


Chartmill TA Rating
Chartmill Setup Rating

1WST.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to 1WST.MI. Both the health and profitability get an excellent rating, making 1WST.MI a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1WST.MI Earnings

On February 12, 2026 1WST.MI reported an EPS of 2.04 and a revenue of 805.00M. The company beat EPS expectations (10.24% surprise) and beat revenue expectations (0.33% surprise).

Next Earnings DateApr 22, 2026
Last Earnings DateFeb 12, 2026
PeriodQ4 / 2025
EPS Reported$2.04
Revenue Reported805M
EPS Surprise 10.24%
Revenue Surprise 0.33%

1WST.MI Forecast & Estimates

23 analysts have analysed 1WST.MI and the average price target is 283.43 EUR. This implies a price increase of 32.45% is expected in the next year compared to the current price of 214.

For the next year, analysts expect an EPS growth of 11.14% and a revenue growth 6.01% for 1WST.MI


Analysts
Analysts80.87
Price Target283.43 (32.44%)
EPS Next Y11.14%
Revenue Next Year6.01%

1WST.MI Groups

Sector & Classification

Index Membership

1WST.MI Financial Highlights

Over the last trailing twelve months 1WST.MI reported a non-GAAP Earnings per Share(EPS) of 6.31. The EPS increased by 8% compared to the year before.


Income Statements
Revenue(TTM)3.07B
Net Income(TTM)493.70M
Industry RankSector Rank
PM (TTM) 16.06%
ROA 11.56%
ROE 15.54%
Debt/Equity 0.06
Chartmill High Growth Momentum
EPS Q2Q%12.09%
Sales Q2Q%7.51%
EPS 1Y (TTM)8%
Revenue 1Y (TTM)6.25%

1WST.MI Ownership

Ownership
Inst Owners97.62%
Shares72.02M
Float71.36M
Ins Owners0.33%
Short Float %N/A
Short RatioN/A

1WST.MI Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
56S1 SARTORIUS STEDIM BIOTECH31.7416.259B
SRT3 SARTORIUS AG-VORZUG36.0115.702B
DIM SARTORIUS STEDIM BIOTECH30.5115.626B
SRT SARTORIUS AG28.3312.355B
QIA QIAGEN N.V.15.97.426B
1SXP SCHOTT PHARMA AG& CO KGAA12.432.042B
EVT EVOTEC SE N/A1.483B
GXI GERRESHEIMER AG6.75610.322M
FF FINE FOODS & PHARMACEUTICALS13.04200.746M
MLC MALIN CORP PLC N/A

About 1WST.MI

Company Profile

1WST logo image West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,800 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Company Info

IPO: 1923-07-27

WEST PHARMACEUTICAL SERVICES

530 Herman O. West Drive

Exton PENNSYLVANIA US

Employees: 10800

1WST Company Website

1WST Investor Relations

Phone: 18006222300

WEST PHARMACEUTICAL SERVICES / 1WST.MI FAQ

What does 1WST do?

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,800 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.


What is the current price of 1WST stock?

The current stock price of 1WST.MI is 214 EUR.


What is the dividend status of WEST PHARMACEUTICAL SERVICES?

WEST PHARMACEUTICAL SERVICES (1WST.MI) has a dividend yield of 0.32%. The yearly dividend amount is currently 0.74.


What is the ChartMill rating of WEST PHARMACEUTICAL SERVICES stock?

1WST.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


Can you provide the market cap for WEST PHARMACEUTICAL SERVICES?

WEST PHARMACEUTICAL SERVICES (1WST.MI) has a market capitalization of 15.41B EUR. This makes 1WST.MI a Large Cap stock.